Evidence map›Paper›PMID 35308823›Full record

ArticleFrontiers in bioengineering and biotechnology2021

YALIcloneNHEJ: An Efficient Modular Cloning Toolkit for NHEJ Integration of Multigene Pathway and Terpenoid Production in

Ya-Wen Li, Cai-Ling Yang, Qi Shen, Qian-Qian Peng, Qi Guo, Zhi-Kui Nie, Xiao-Man Sun, Tian-Qiong Shi, Xiao-Jun Ji, He Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Development of a greenSynthetic and systems biotechnology · 2025
    Article
  10. Review
  11. Developing polycistronic expression tool inSynthetic and systems biotechnology · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. EngineeringSynthetic and systems biotechnology · 2023
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ya-Wen LiSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Cai-Ling YangSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Qi ShenSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Qian-Qian PengSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Qi GuoCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Zhi-Kui NieJiangxi New Reyphon Biochemical Co., Ltd., Salt and Chemical Industry, Xingan, China.
Xiao-Man SunSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Tian-Qiong ShiSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Xiao-Jun JiCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
He HuangSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
Nanjing Normal University · CNNanjing Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-homologous end-joining (NHEJ)-mediated random integration in

Indexed as

Golden Gate cloningnon-homologous end-joiningsesquiterpeneY. lipolytica(-)-α-bisabolol

Identifiers

PMID35308823
PMCPMC8924588
OpenAlexW4214822728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.